Irfen 200 mg film-coated tablet Malta - English - Medicines Authority

irfen 200 mg film-coated tablet

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - ibuprofen - film-coated tablet - ibuprofen 200 mg - antiinflammatory and antirheumatic products

Irfen 400 mg film-coated tablet Malta - English - Medicines Authority

irfen 400 mg film-coated tablet

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - ibuprofen - film-coated tablet - ibuprofen 400 mg - antiinflammatory and antirheumatic products

ORKAMBI 200/125 lumacaftor/ivacaftor 200mg/125mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

orkambi 200/125 lumacaftor/ivacaftor 200mg/125mg film-coated tablet blister pack

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 125 mg; lumacaftor, quantity: 200 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; microcrystalline cellulose; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; purified talc; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350; cochineal; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

VORICONAZOLE SANDOZ voriconazole 200mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

voriconazole sandoz voriconazole 200mg film-coated tablet blister pack

sandoz pty ltd - voriconazole, quantity: 200 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; triacetin - voriconazole sandoz is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy,- prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.,- this brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets. for dosing requirements for populations who require intravenous or oral suspension treatment see dosage and administration.

Ibuprofen/Phenylephrine Clonmel 400 mg/10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ibuprofen/phenylephrine clonmel 400 mg/10 mg film-coated tablets

clonmel healthcare ltd - ibuprofen; phenylephrine hydrochloride - film-coated tablet - 400/10 milligram(s) - other cold preparations

Brufen 400mg film-coated tablets Malta - English - Medicines Authority

brufen 400mg film-coated tablets

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - ibuprofen - film-coated tablet - ibuprofen 400 mg - antiinflammatory and antirheumatic products

ORKAMBI 200 MG 125 MG FILM COATED TABLTES Israel - English - Ministry of Health

orkambi 200 mg 125 mg film coated tabltes

vertex pharmaceuticals (u.k) limited, israel - ivacaftor; lumacaftor - film coated tablets - ivacaftor 125 mg; lumacaftor 200 mg - ivacaftor and lumacaftor - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 12 years and older who are homozygous for the f508del mutation in the cftr gene.if the patient's genotype is unknown, cf mutation test should be used to detect the presence of the f508del mutation on both alleles of the cftr gene.limitations of usethe efficacy and safety of orkambi have not been established in patients with cf other than those homozygous for the f508del mutation.

APAP intense 200 mg/500 mg film-coated tablets Malta - English - Medicines Authority

apap intense 200 mg/500 mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - ibuprofen, paracetamol - film-coated tablet - ibuprofen 200 mg paracetamol 500 mg - antiinflammatory and antirheumatic products

Mybufen 200 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

mybufen 200 mg film-coated tablets

bluefish pharmaceuticals ab - ibuprofen - film-coated tablet - ibuprofen

Mybufen Max 400 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

mybufen max 400 mg film-coated tablets

bluefish pharmaceuticals ab - ibuprofen - film-coated tablet - ibuprofen